RPS19 Deficient Diamond-Blackfan Anemia Clinical Trials in Stanford, California

Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia